Skip to content

Peripheral Nerve Blocks as an alternative to lumbar epidural for the treatment of low back pain

Peripheral Nerve Blocks for the treatment of lumbosacral radiculopathy- an alternative to lumbar epidural: A prospective preliminary study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023147
Enrollment
30
Registered
2020-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G544- Lumbosacral root disorders, not elsewhere classified

Interventions

Intervention1: Peripheral Nerve Block: Patient will receive one or two peripheral nerve blocks at a maximum according to their involvement in the operation theatre, with full ASA monitoring under all

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age more than 18 years. 2. History of segmental low back pain of lumbar or sacral origin with radiation to unilateral lower limb below knee of more than 3 months duration. 3. History of predominant leg pain over back pain. 4. Radicular pain not responding to oral medications and physiotherapy. 5. Pain involving up to two segmental levels (L4, L5 and S1). 6. Average pain score of >=5 on an 11-point NRS. 7. Tenderness over the concordant peripheral nerves (Gore sign +) 8. Lower limb pain centralizes to spine on extension (McKenzeâ??s test +) 9. Computed tomography/Magnetic resonance imaging evidence of nerve root pain concordant with the side and level of clinical features. 10.Informed consent.

Exclusion criteria

Exclusion criteria: 1. Patient refusal to participate. 2. Coagulopathy and/or patients on anticoagulants. 3. Infection at the site of injection. 4. Hypersensitivity to local anesthetic agent. 5. Evidence of significant sensory or progressive motor deficit. 6. Evidence of severe psychiatric illness. 7. Presence of cancer as a cause of back pain. 8. History of previous backs surgery/epidural steroid injection. 9.Presence of diabetes mellitus, multiple sclerosis, cardiac pacemaker, pregnancy.

Design outcomes

Primary

MeasureTime frame
1. â?¥50% or â?¥4 point reduction in an 11-point numeric scale (NRS 11) at 2 weeks, 1 month, 2 months and 3 months. 2. â?¥50% or â?¥6 points improvement in GPE (Global Perceived Effect) at 2 weeks, 1 month, 2 months and 3 months as measured by Likert scale 7-point scoring system to assess patient satisfaction and improvement. Timepoint: 1. â?¥50% or â?¥4 point reduction in an 11-point numeric scale (NRS 11) at 2 weeks, 1 month, 2 months and 3 months. 2. â?¥50% or â?¥6 points improvement in GPE (Global Perceived Effect) at 2 weeks, 1 month, 2 months and 3 months as measured by Likert scale 7-point scoring system to assess patient satisfaction and improvement.

Secondary

MeasureTime frame
1. Mean NRS (Numerical Rating Scale) and improvement in functional status as measured by Ronald Morris Questionnaire at respective time intervals. 2. Employment status. 3. Analgesic requirements and 4. Procedural complications. Timepoint: 2 weeks, 1month ,2 months, 3 months

Countries

India

Contacts

Public ContactDr Praveen Talawar

All India Institute Of Medical Sciences Rishikesh

praveenrt64@gmail.com9654162941

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026